Royal Bank of Canada is a leading financial services institution that provides a wide range of banking and financial solutions to individuals, businesses, and institutions. The bank offers personal and commercial banking services, wealth management, investment banking, and capital markets services. With a robust network of branch locations and digital platforms, it aims to meet the diverse needs of its clients while focusing on innovation and customer service. Royal Bank of Canada is committed to enhancing the financial well-being of its customers and leveraging its expertise to support economic growth in the communities it serves. Read More
The Wall Street Journal highlighted UHS, THC and HCA as key beneficiaries of Medicaid supplemental payment programs that cost the federal government hundreds of billions.
The burrito chain has maintained that it will not increase the prices of its menu items and will offset higher input costs through automation and other initiatives.
The company expects quarterly adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) to exceed $22.5 million once final numbers are reported, exceeding expectations of $14.78 million.
RBC Capital opined that Pacira's settlement of litigation for generic Exparel, which provides some closure to over a year's worth of overhang and uncertainty for shares, is a win for the company and the Exparel franchise.
Retailers and consumer-facing companies are reeling more prominently as they fear the potential hike to consumer prices of their products will directly hurt sales.
RBC Capital Markets analyst maintains BlackBerry with Sector Perform rating, lowers price target to $3.75 due to lower revenue and EBITDA guidance for fiscal 2026.
The brokerage highlighted that the outlook for residential demand for Enphase’s products remains challenged due to worsening sentiment with respect to the Inflation Reduction Act.
April 2, 2025 – Tesla, Inc. (NQ:TSLA) shares fell sharply in morning trading today after the electric vehicle giant reported first-quarter vehicle deliveries that significantly undershot Wall Street expectations. At 11:14:02 AM EDT, Tesla’s stock price stood at $265.62, reflecting a decline of $2.84, or
The sector's recent slide follows Peter Marks' resignation last week as the Food and Drug Administration's top vaccine regulator following a clash with Kennedy.
Earlier, analysts at RBC Capital noted that while Enphase has a strong opportunity to return to growth eventually, in the near term, the company continues to cede market share amid softening demand.
